SCHEMBL16703979

SCHEMBL16703979

CC1Oc2c(N3CCNCC3)cccc2N(C)C1=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 3/20 0.53
ADRB1 P08588 4/20 0.46
HTR6 P50406 4/20 0.42
HTR1A P08908 2/20 0.42
HTR2A P28223 2/20 0.42
DRD3 P35462 2/20 0.42
DRD4 P21917 1/20 0.42
HTR2C P28335 1/20 0.42
HTR7 P34969 2/20 0.40
HTR3E A5X5Y0 1/20 0.40
HTR3B O95264 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
NCF1 P14598 1/20 0.40
TSHR P16473 1/20 0.40
NFKB1 P19838 1/20 0.40
HTR1D P28221 1/20 0.40
HTR1B P28222 1/20 0.40
MTOR P42345 1/20 0.40
HTR3A P46098 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13672068 1.00 DRD2 (0.53) DRD2ADRB1HTR6HTR1AHTR2A
SCHEMBL4675159 0.79 HTR6 (0.64) DRD2HTR6HTR1AHTR2ADRD3
SCHEMBL4675195 0.79 HTR6 (0.64) DRD2HTR6HTR1AHTR2ADRD3
SCHEMBL4674919 0.79 HTR6 (0.64) DRD2HTR6HTR1AHTR2ADRD3
SCHEMBL13672065 0.77 DRD2 (0.53) DRD2ADRB1HTR1AHTR2ADRD3
SCHEMBL13672071 0.74 DRD2 (0.41) DRD2TSHRPDE3BPDE3A
SCHEMBL31052166 0.71 ADRB1 (0.57) DRD2ADRB1HTR6HTR1AHTR2A
SCHEMBL5363483 0.71 ADRB1 (0.47) DRD2ADRB1HTR6HTR1AHTR2A
SCHEMBL10068900 0.69 DRD2 (0.39) DRD2TSHRPDE3BPDE3A
SCHEMBL5371851 0.69 ADRB1 (0.47) DRD2ADRB1HTR6HTR1AHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015069110-A1 MULTIPLE D2 A(NTA)GONISTS/H3 ANTAGONISTS FOR TREATMENT OF CNS-RELATED DISORDERS AAPA B.V. (NL) 2015-05-14 WO disclosed
WO-2015069110-A1 MULTIPLE D2 A(NTA)GONISTS/H3 ANTAGONISTS FOR TREATMENT OF CNS-RELATED DISORDERS AAPA B.V. (NL) 2015-05-14 WO disclosed